Does daily supplementation of D-ribose show no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis?
Treatment with daily oral doses of D-ribose showed no significant effect on either disease progression or muscle function in the mouse model of myositis.
uNGAL identifies kidney injury in unilateral and bilateral UTO even in the absence of an elevated sCr.